Adverum Biotechnologies (ADVM)
(Real Time Quote from BATS)
$7.95 USD
+0.17 (2.19%)
Updated Jul 11, 2024 12:14 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Adverum Biotechnologies, Inc. [ADVM]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Top 23 Takeaways From Our Coverage at the H.C. Wainwright Bioconnect Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Looking to LUNA - Phase 2 Interim 26-Week Analysis Expected In Near Term; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Novel Gene Therapy Prospect in Wet AMD-Phase 2 Interim Data Expected Mid-2024; Initiating With Buy Rating and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Catching The Next Wave of Innovation: Highlights from Vitreoretinal KOL Call
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adverum Biotechnologies, Inc.
Industry: Medical - Biomedical and Genetics
Highlights from wAMD Key Opinion Leader Call: Treat and Extend; Once and Done
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
|